Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEVICONTROL-2
2011-004249-42Phase 4Completed
- Sponsor
- IPPMed
- Start
- Sep 2011
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of olmesartan, amlodipine and candesartan in hypertension (HTN), sponsored by IPPMed. Primary endpoint: Change in systolic daytime mean ambulatory blood pressure. Started Sep 2011; status: completed.
02
Drugs
olmesartanamlodipinecandesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2011-004249-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004249-42.